15. Michel LS, Liberal V, Chatterjee A, Kirchwegger R, Pasche B, et al. (2001) MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature 409: 355–359. 16. Hanks S, Coleman K, Reid S, Plaja A, Firth H, et al. (2004) Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nat Genet 36: 1159–1161. 17. Schvartzman J-M, Sotillo R, Benezra R (2010) Mitotic chromosomal instability and cancer: mouse modelling of the human disease. Nat Rev Cancer 10: 102– 115. 18. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, et al. (2007) The Genomic Landscapes of Human Breast and Colorectal Cancers. Science 318: 1108–1113. 19. Cimini D, Howell B, Maddox P, Khodjakov A, Degrassi F, et al. (2001) Merotelic Kinetochore Orientation Is a Major Mechanism of Aneuploidy in Mitotic Mammalian Tissue Cells. The Journal of Cell Biology 153: 517–528. 20. Hollstein M, Sidransky D, Vogelstein B, Harris C (1991) p53 mutations in human cancers. Science 253: 49–53. 21. Burds AA, Lutum AS, Sorger PK (2005) Generating chromosome instability through the simultaneous deletion of Mad2 and p53. Proceedings of the National Academy of Sciences of the United States of America 102: 11296– 11301. 22. Kasiappan R, Shih H-J, Chu K-L, Chen W-T, Liu H-P, et al. (2009) Loss of p53 and MCT-1 Overexpression Synergistically Promote Chromosome Instability and Tumorigenicity. Molecular Cancer Research 7: 536–548. 23. Yunis J (1983) The chromosomal basis of human neoplasia. Science 221: 227– 236. 24. Mitelman F, Johansson B, Mandahl N, Mertens F (1997) Clinical significance of cytogenetic findings in solid tumors. Cancer Genetics and Cytogenetics 95: 1–8. 25. Buffin E, Emre D, Karess RE (2007) Flies without a spindle checkpoint. Nat Cell Biol 9: 565–572. 26. Prencipe M, McGoldrick A, Perry AS, O’Grady A, Phelan S, et al. (2010) MAD2 downregulation in hypoxia is independent of promoter hypermethyla- tion. Cell Cycle 9: 2856–2865. 27. Furlong F, Fitzpatrick P, O’Toole S, Phelan S, McGrogan B, et al. (2012) Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer. The Journal of Pathology 226: 746–755. 28. Zhang J, Neisa R, Mao Y (2009) Oncogenic Adenomatous Polyposis Coli Mutants Impair the Mitotic Checkpoint through Direct Interaction with Mad2. Molecular Biology of the Cell 20: 2381–2388. 29. Dikovskaya D, Schiffmann D, Newton IP, Oakley A, Kroboth K, et al. (2007) Loss of APC induces polyploidy as a result of a combination of defects in mitosis and apoptosis. The Journal of Cell Biology 176: 183–195. 30. Draviam VM, Shapiro I, Aldridge B, Sorger PK (2006) Misorientation and reduced stretching of aligned sister kinetochores promote chromosome missegregation in EB1- or APC-depleted cells. EMBO J 25: 2814–2827. 31. Hunter T (2000) Signaling–2000 and Beyond. Cell 100: 113–127. 32. Blume-Jensen P, Hunter T (2001) Oncogenic kinase signalling. Nature 411: 355–365. 33. Zhang J, Yang PL, Gray NS (2009) Targeting cancer with small molecule kinase inhibitors. Nat Rev Cancer 9: 28–39. 34. Suzuki K, Kokuryo T, Senga T, Yokoyama Y, Nagino M, et al. (2010) Novel combination treatment for colorectal cancer using Nek2 siRNA and cisplatin. Cancer Science 101: 1163–1169. 35. Weaver BAA, Cleveland DW (2009) The role of aneuploidy in promoting and suppressing tumors. The Journal of Cell Biology 185: 935–937. 36. Janssen A, Kops GJPL, Medema RH (2009) Elevating the frequency of chromosome mis-segregation as a strategy to kill tumor cells. Proceedings of the National Academy of Sciences 106: 19108–19113. 37. Mills KD, Ferguson DO, Alt FW (2003) The role of DNA breaks in genomic instability and tumorigenesis. Immunological Reviews 194: 77–95. 38. Kaye JA, Melo JA, Cheung SK, Vaze MB, Haber JE, et al. (2004) DNA Breaks Promote Genomic Instability by Impeding Proper Chromosome Segregation. Current Biology 14: 2096–2106. 39. Orr B, Bousbaa H, Sunkel CE (2007) Mad2-independent Spindle Assembly Checkpoint Activation and Controlled Metaphase–Anaphase Transition in Drosophila S2 Cells. Molecular Biology of the Cell 18: 850–863. 40. Roschke AV, Kirsch IR (2005) Targeting Cancer Cells by Exploiting Karyotypic Complexity and Chromosomal Instability. Cell Cycle 4: 679–682. 41. Duensing A, Duensing S (2010) Centrosomes, polyploidy and cancer. Adv Exp Med Biol 676: 93–103. 42. Mazzorana M, Montoya G, B. Mortuza G (2011) The Centrosome: A Target for Cancer Therapy. Current Cancer Drug Targets 11: 600–612. 43. Galimberti F, Thompson SL, Ravi S, Compton DA, Dmitrovsky E (2011) Anaphase Catastrophe Is a Target for Cancer Therapy. Clinical Cancer Research 17: 1218–1222. 44. Wagner EF, Nebreda AR (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9: 537–549. 45. McEwen DG, Peifer M (2005) Puckered, a Drosophila MAPK phosphatase, ensures cell viability by antagonizing JNK-induced apoptosis. Development 132: 3935–3946. Killing Cells with Chromosomal Instability 46. Gutierrez GJ, Tsuji T, Cross JV, Davis RJ, Templeton DJ, et al. (2010) JNK- mediated Phosphorylation of Cdc25C Regulates Cell Cycle Entry and G2/M DNA Damage Checkpoint. Journal of Biological Chemistry 285: 14217–14228. 47. Wakefield JG, Bonaccorsi S, Gatti M (2001) The Drosophila Protein Asp Is Involved in Microtubule Organization during Spindle Formation and Cytokinesis. The Journal of Cell Biology 153: 637–648. 48. Lunardi A, Di Minin G, Provero P, Dal Ferro M, Carotti M, et al. (2010) A genome-scale protein interaction profile of Drosophila p53 uncovers additional nodes of the human p53 network. Proceedings of the National Academy of Sciences 107: 6322–6327. 49. Ma Z, Izumi H, Kanai M, Kabuyama Y, Ahn NG, et al. (2006) Mortalin controls centrosome duplication via modulating centrosomal localization of p53. Oncogene 25: 5377–5390. 50. Tritarelli A, Oricchio E, Ciciarello M, Mangiacasale R, Palena A, et al. (2004) p53 Localization at Centrosomes during Mitosis and Postmitotic Checkpoint Are ATM-dependent and Require Serine 15 Phosphorylation. Molecular Biology of the Cell 15: 3751–3757. 51. Liu Q, Hirohashi Y, Du X, Greene MI, Wang Q (2010) Nek2 targets the mitotic checkpoint proteins Mad2 and Cdc20: A mechanism for aneuploidy in cancer. Experimental and Molecular Pathology 88: 225–233. 52. Schla¨fli P, Borter E, Spielmann P, Wenger R (2009) The PAS-domain kinase PASKIN: a new sensor in energy homeostasis. Cellular and Molecular Life Sciences 66: 876–883. 53. MacDonald P, Rorsman P (2011) Per-arnt-sim (PAS) domain kinase (PASK) as a regulator of glucagon secretion. Diabetologia 54: 719–721. 54. Crasta K, Ganem NJ, Dagher R, Lantermann AB, Ivanova EV, et al. (2012) DNA breaks and chromosome pulverization from errors in mitosis. Nature advance online publication. 55. Dotiwala F, Harrison JC, Jain S, Sugawara N, Haber JE (2010) Mad2 Prolongs DNA Damage Checkpoint Arrest Caused by a Double-Strand Break via a Centromere-Dependent Mechanism. Current Biology 20: 328–332. 56. Petitjean A, Achatz MIW, Borresen-Dale AL, Hainaut P, Olivier M (2007) TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene 26: 2157–2165. 57. Bogoyevitch MA, Arthur PG (2008) Inhibitors of c-Jun N-terminal kinases’’ JuNK no more? Biochimica et Biophysica Acta (BBA) - Proteins & Proteomics 1784: 76–93. 58. Bogoyevitch MA, Ngoei KRW, Zhao TT, Yeap YYC, Ng DCH (2009) c-Jun N- terminal kinase (JNK) signaling: Recent advances and challenges. Biochimica et Biophysica Acta (BBA) - Proteins & Proteomics 1804: 463–475. 59. Lawlor KT, O’Keefe LV, Samaraweera SE, van Eyk CL, McLeod CJ, et al. (2011) Double-stranded RNA is pathogenic in Drosophila models of expanded repeat neurodegenerative diseases. Human Molecular Genetics 20: 3757–3768. 60. Williams BC, Goldberg ML (1994) Determinants of Drosophila zw10 protein localization and function. Journal of Cell Science 107: 785–798. 61. Sonn S, Oh GT, Rhee K (2011) Nek2 and its substrate, centrobin/Nip2, are required for proper meiotic spindle formation of the mouse oocytes. Zygote 19: 15–20. 62. Smith J, Mun Tho L, Xu N, A. Gillespie D (2010) The ATM-Chk2 and ATR- Chk1 pathways in DNA damage signaling and cancer. Advances in Cancer Research. 73–112. 63. Stronach B (2005) Dissecting JNK signaling, one KKKinase at a time. Developmental Dynamics 232: 575–584. 64. Ishimaru S, Ueda R, Hinohara Y, Ohtani M, Hanafusa H (2004) PVR plays a critical role via JNK activation in thorax closure during Drosophila metamorphosis. EMBO J 23: 3984–3994. 65. Polaski S, Whitney L, Barker BW, Stronach B (2006) Genetic Analysis of Slipper/Mixed Lineage Kinase Reveals Requirements in Multiple Jun-N- Terminal Kinase-Dependent Morphogenetic Events During Drosophila Devel- opment. Genetics 174: 719–733. 66. Liu RX, Wang WQ, Ye L, Bi YF, Fang H, et al. (2010) p21-Activated kinase 3 is overexpressed in thymic neuroendocrine tumors (carcinoids) with ectopic ACTH syndrome and participates in cell migration. Endocrine 38: 38–47. 67. Menzel N, Schneeberger D, Raabe T (2007) The Drosophila p21 activated kinase Mbt regulates the actin cytoskeleton and adherens junctions to control photoreceptor cell morphogenesis. Mechanisms of Development 124: 78–90. 68. De A (2011) Wnt/Ca2+ signaling pathway: a brief overview. Acta Biochimica et Biophysica Sinica 43: 745–756. 69. Moniz S, Jordan P (2010) Emerging roles for WNK kinases in cancer. Cellular and Molecular Life Sciences 67: 1265–1276. 70. Aihara H, Nakagawa T, Yasui K, Ohta T, Hirose S, et al. (2004) Nucleosomal histone kinase-1 phosphorylates H2A Thr 119 during mitosis in the early Drosophila embryo. Genes & Development 18: 877–888. 71. Kawajiri S, Saiki S, Sato S, Hattori N (2011) Genetic mutations and functions of PINK1. Trends in pharmacological sciences 32: 573–580. 72. Shiryaev A, Moens U (2010) Mitogen-activated protein kinase p38 and MK2, MK3 and MK5: Me´nage a` trois or me´nage a` quatre? Cellular Signalling 22: 1185–1192. PLOS ONE | www.plosone.org 10 October 2012 | Volume 7 | Issue 10 | e47447